Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poole

Showing results (741-750 of 1,034) with videos related to

Pageof 104
Sort By:
British Journal of Clinical Pharmacology|February 1, 1987
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failureR Canepa-Anson, J R Dawson, P Kuan, et al.
Lancet (London, England)|April 4, 2003
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyStefan D Anker, Abdissa Negassa, Andrew J S Coats, et al.
The Biochemical Journal|October 15, 1995
Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptorF Yanaga, A Poole, J Asselin, et al.
Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.
European Heart Journal|December 1, 1982
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmiasR Canepa-Anson, J R Dawson, W S Frankl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2025
Authors' responseJennilee Luedders, Sara May, Elizabeth Lyden, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|March 27, 2023
METASTATIC MINERALIZATION IN A ZOOLOGIC COLLECTION OF SPOT-TAILED EARLESS LIZARDS (<i>HOLBROOKIA</i>SPP.)Sarah A Cannizzo, Adam Reppert, Ann Ward, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 7, 2019
Amphiregulin modulates murine lung recovery and fibroblast function following exposure to agriculture organic dustJill A Poole, Tara M Nordgren, Art J Heires, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
Cell Biology International|February 27, 2004
Ultrastructural, tomographic and confocal imaging of the chondrocyte primary cilium in situC G Jensen, C A Poole, S R McGlashan, et al.
Pageof 104

Showing results (741-750 of 1,034) with videos related to

Sort By:
Pageof 104
British Journal of Clinical Pharmacology|February 1, 1987
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failureR Canepa-Anson, J R Dawson, P Kuan, et al.
Lancet (London, England)|April 4, 2003
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyStefan D Anker, Abdissa Negassa, Andrew J S Coats, et al.
The Biochemical Journal|October 15, 1995
Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptorF Yanaga, A Poole, J Asselin, et al.
Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.
European Heart Journal|December 1, 1982
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmiasR Canepa-Anson, J R Dawson, W S Frankl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2025
Authors' responseJennilee Luedders, Sara May, Elizabeth Lyden, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|March 27, 2023
METASTATIC MINERALIZATION IN A ZOOLOGIC COLLECTION OF SPOT-TAILED EARLESS LIZARDS (<i>HOLBROOKIA</i>SPP.)Sarah A Cannizzo, Adam Reppert, Ann Ward, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 7, 2019
Amphiregulin modulates murine lung recovery and fibroblast function following exposure to agriculture organic dustJill A Poole, Tara M Nordgren, Art J Heires, et al.
European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.
Cell Biology International|February 27, 2004
Ultrastructural, tomographic and confocal imaging of the chondrocyte primary cilium in situC G Jensen, C A Poole, S R McGlashan, et al.
Pageof 104